Electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo

Maria Dąbkowska,1 Dorota Rogińska,2 Patrycja Kłos,1 Anna Sobuś,2 Małgorzata Adamczak,3 Zofia Litwińska,2 Anna Machalińska,4 Bogusław Machaliński21Department of Medical Chemistry, Pomeranian Medical University, Szczecin 70-204, Poland; 2Department of General Pathology, Pomeranian Medical University,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dąbkowska M, Rogińska D, Kłos P, Sobuś A, Adamczak M, Litwińska Z, Machalińska A, Machaliński B
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	neurotrophin 4 (NT-4) retinal pigment epithelium therapeutic protein dendrimer functionalization controlled release of protein NT-4-PAMAM electrostatic complex Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/2d1fddd992fe490889c9223400d4ba15
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:2d1fddd992fe490889c9223400d4ba15
record_format	dspace
spelling	oai:doaj.org-article:2d1fddd992fe490889c9223400d4ba152021-12-02T02:42:46ZElectrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo1178-2013https://doaj.org/article/2d1fddd992fe490889c9223400d4ba152019-08-01T00:00:00Zhttps://www.dovepress.com/electrostatic-complex-of-neurotrophin-4-with-dendrimer-nanoparticles-c-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Maria Dąbkowska,1 Dorota Rogińska,2 Patrycja Kłos,1 Anna Sobuś,2 Małgorzata Adamczak,3 Zofia Litwińska,2 Anna Machalińska,4 Bogusław Machaliński21Department of Medical Chemistry, Pomeranian Medical University, Szczecin 70-204, Poland; 2Department of General Pathology, Pomeranian Medical University, Szczecin 70-204, Poland; 3Department of Pharmacy, School of Pharmacy, University of Oslo, Blindern, Oslo 0316, Norway; 4First Department of Ophthalmology, Pomeranian Medical University, Szczecin 70-204, PolandBackground: NT4 has been regarded as a promising therapeutic protein for treatment of damaged retinal pigment epithelium cells.Purpose: Here, we studied physicochemical parameters of an NT4–polyamidoamine (PAMAM) electrostatic complex, which can provide a sustained concentration of protein in intraocular space over an extended period after delivery. Adsorption/desorption of NT4 molecules to/from positively charged PAMAM dendrimers were precisely determined to control the concentration of bounded/unbounded protein molecules, diffusion coefficient, and size of a protein-laden dendrimer structure. We determined kinetics of NT4 desorption in PBS, vitreous, and damaged retina.Methods: Initially, adsorption of NT4 molecules on PAMAM dendrimers was studied in PBS using dynamic light scattering, electrophoresis, solution depletion, ELISA, and atomic force microscopy. This allowed us precisely to determine desorption of NT4 from nanoparticles under in situ conditions. The maximum coverage of irreversibly adsorbed NT4 determined by ELISA allowed us to devise a robust procedure for preparing stable and well-controlled coverage of NT4 on PAMAM nanoparticles. Thereafter, we studied diffusion of nanospheres containing NT4 molecules by injecting them into vitreous cavities of mice exposed to intravenous injections of sodium iodate and evaluated their intraocular desorption kinetics from drug carriers in vivo.Results: Our measurements revealed NT4–dendrimer nanoparticles can be used for continuous neurotrophic factor delivery, enhancing its distribution into mouse vitreous, as well as damaged retina over 28 days of postinjury observation.Conclusion: Understanding of polyvalent neurotrophin interactions with dendrimer nanoparticles might be useful to obtain well-ordered protein layers, targeting future development of drug-delivery systems, especially for neuroprotection of damaged retinal neurons.Keywords: neurotrophin 4, NT4, retinal pigment epithelium, therapeutic protein, dendrimer functionalization, controlled release of protein, NT4–PAMAM electrostatic complexDąbkowska MRogińska DKłos PSobuś AAdamczak MLitwińska ZMachalińska AMachaliński BDove Medical Pressarticleneurotrophin 4 (NT-4)retinal pigment epitheliumtherapeutic proteindendrimer functionalizationcontrolled release of proteinNT-4-PAMAM electrostatic complexMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 6117-6131 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	neurotrophin 4 (NT-4) retinal pigment epithelium therapeutic protein dendrimer functionalization controlled release of protein NT-4-PAMAM electrostatic complex Medicine (General) R5-920
spellingShingle	neurotrophin 4 (NT-4) retinal pigment epithelium therapeutic protein dendrimer functionalization controlled release of protein NT-4-PAMAM electrostatic complex Medicine (General) R5-920 Dąbkowska M Rogińska D Kłos P Sobuś A Adamczak M Litwińska Z Machalińska A Machaliński B Electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo
description	Maria Dąbkowska,1 Dorota Rogińska,2 Patrycja Kłos,1 Anna Sobuś,2 Małgorzata Adamczak,3 Zofia Litwińska,2 Anna Machalińska,4 Bogusław Machaliński21Department of Medical Chemistry, Pomeranian Medical University, Szczecin 70-204, Poland; 2Department of General Pathology, Pomeranian Medical University, Szczecin 70-204, Poland; 3Department of Pharmacy, School of Pharmacy, University of Oslo, Blindern, Oslo 0316, Norway; 4First Department of Ophthalmology, Pomeranian Medical University, Szczecin 70-204, PolandBackground: NT4 has been regarded as a promising therapeutic protein for treatment of damaged retinal pigment epithelium cells.Purpose: Here, we studied physicochemical parameters of an NT4–polyamidoamine (PAMAM) electrostatic complex, which can provide a sustained concentration of protein in intraocular space over an extended period after delivery. Adsorption/desorption of NT4 molecules to/from positively charged PAMAM dendrimers were precisely determined to control the concentration of bounded/unbounded protein molecules, diffusion coefficient, and size of a protein-laden dendrimer structure. We determined kinetics of NT4 desorption in PBS, vitreous, and damaged retina.Methods: Initially, adsorption of NT4 molecules on PAMAM dendrimers was studied in PBS using dynamic light scattering, electrophoresis, solution depletion, ELISA, and atomic force microscopy. This allowed us precisely to determine desorption of NT4 from nanoparticles under in situ conditions. The maximum coverage of irreversibly adsorbed NT4 determined by ELISA allowed us to devise a robust procedure for preparing stable and well-controlled coverage of NT4 on PAMAM nanoparticles. Thereafter, we studied diffusion of nanospheres containing NT4 molecules by injecting them into vitreous cavities of mice exposed to intravenous injections of sodium iodate and evaluated their intraocular desorption kinetics from drug carriers in vivo.Results: Our measurements revealed NT4–dendrimer nanoparticles can be used for continuous neurotrophic factor delivery, enhancing its distribution into mouse vitreous, as well as damaged retina over 28 days of postinjury observation.Conclusion: Understanding of polyvalent neurotrophin interactions with dendrimer nanoparticles might be useful to obtain well-ordered protein layers, targeting future development of drug-delivery systems, especially for neuroprotection of damaged retinal neurons.Keywords: neurotrophin 4, NT4, retinal pigment epithelium, therapeutic protein, dendrimer functionalization, controlled release of protein, NT4–PAMAM electrostatic complex
format	article
author	Dąbkowska M Rogińska D Kłos P Sobuś A Adamczak M Litwińska Z Machalińska A Machaliński B
author_facet	Dąbkowska M Rogińska D Kłos P Sobuś A Adamczak M Litwińska Z Machalińska A Machaliński B
author_sort	Dąbkowska M
title	Electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo
title_short	Electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo
title_full	Electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo
title_fullStr	Electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo
title_full_unstemmed	Electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo
title_sort	electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/2d1fddd992fe490889c9223400d4ba15
work_keys_str_mv	AT dabkowskam electrostaticcomplexofneurotrophin4withdendrimernanoparticlescontrolledreleaseofproteininvitroandinvivo AT roginskad electrostaticcomplexofneurotrophin4withdendrimernanoparticlescontrolledreleaseofproteininvitroandinvivo AT kłosp electrostaticcomplexofneurotrophin4withdendrimernanoparticlescontrolledreleaseofproteininvitroandinvivo AT sobusa electrostaticcomplexofneurotrophin4withdendrimernanoparticlescontrolledreleaseofproteininvitroandinvivo AT adamczakm electrostaticcomplexofneurotrophin4withdendrimernanoparticlescontrolledreleaseofproteininvitroandinvivo AT litwinskaz electrostaticcomplexofneurotrophin4withdendrimernanoparticlescontrolledreleaseofproteininvitroandinvivo AT machalinskaa electrostaticcomplexofneurotrophin4withdendrimernanoparticlescontrolledreleaseofproteininvitroandinvivo AT machalinskib electrostaticcomplexofneurotrophin4withdendrimernanoparticlescontrolledreleaseofproteininvitroandinvivo
_version_	1718402207904169984

Electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo

Ejemplares similares